IPO Year: 2024
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|
SINGAPORE, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it would host a conference call on Thursday, October 24th, 2024, at 8:00 AM ET to discuss the company's Fiscal Year 2024 financial results ended June 30th, 2024. These results will be announced on Wednesday, October 23rd, shortly after 4:00 PM ET. To participate in the conference call, please dial 1-800-445-7795 or 1-203-518-9783 approximately 5 to 10 minutes before the beginning of the call, using the Conference ID "MNDR." The Company will be answering questions live on the conference call, and inve
20-F/A - Mobile-health Network Solutions (0001976695) (Filer)
20-F - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
6-K/A - Mobile-health Network Solutions (0001976695) (Filer)
6-K - Mobile-health Network Solutions (0001976695) (Filer)
SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal year 2024 ended June 30, 2024, the Company had revenue of $14.0 million, a $6.1 million, or 77 percent, improvement on revenue of $7.9 million for fiscal 2023. This improvement was due to increased revenue of $6.0 million contributed by the Company's telemedicine and other services segment, and $0.1 million by MNDR's sale of medicine and medical devices segment. Cost of revenue increased by $4.7 million, or 69 percent, in fiscal 2024, mainly due to a 70 percent increase in the number of
SINGAPORE, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it would host a conference call on Thursday, October 24th, 2024, at 8:00 AM ET to discuss the company's Fiscal Year 2024 financial results ended June 30th, 2024. These results will be announced on Wednesday, October 23rd, shortly after 4:00 PM ET. To participate in the conference call, please dial 1-800-445-7795 or 1-203-518-9783 approximately 5 to 10 minutes before the beginning of the call, using the Conference ID "MNDR." The Company will be answering questions live on the conference call, and inve
SINGAPORE, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that the Company will attend and present at the following financial conferences: Lytham Partners Fall 2024 Investor Conference Conference Date: Tuesday, October 1, 2024Conference Location: Virtual Company Presentation: October 1, 2024, at 3:30-4:00 PM ET To watch the Company Presentation virtually, please go here or contact Lytham Partners at [email protected] to register for the event and schedule a meeting with our company. Additionally, we will conduct a fireside chat moderated by Barry Sine, Equity
SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a notice dated September 18, 2024, from the Listings Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share of its Class A ordinary shares ("Class A Ordinary Shares") was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"). The Nasdaq notification letter does not re
SINGAPORE, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced Dr. Siaw Tung Yeng and Dr. Rachel Teoh Pui Pui, Co-Founders and Co-CEOs, will present and host one-on-one meetings with investors at the Sidoti August Virtual Investor Conference, taking place on August 14-15, 2024. Joining them will be Law Pei Bei, Chief Business Officer, Peng Chee Yong, Chief Financial Officer, and Lan Kangming, Investor Relations Officer. The presentation will begin at 8:30 AM ET on Wednesday, August 14 and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_1RrAEeydShatO
Ryde Group Ltd (NYSE:RYDE) ("Ryde" or "the Company"), a leading technology platform for mobility and quick commerce, today announced a partnership with Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr"), the first US listed telehealth provider in Asia Pacific. Ryde and MaNaDr signed a definitive partnership agreement to further collaboration in the telehealth and quick commerce space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240627298820/en/(Left to right: Dr Rachel Teoh, Co-Founder and Co-CEO, Dr Siaw Tung Yeng, Co-Founder and Co-CEO, Mr. Terence Zou, Founder, Chairman, and CEO & Mr. Nitin Dolli, Chief Technology Of
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announces the latest major update to its cloud-based MaNaDr AI-Powered Health Operating System ("MHOS") designed to transform healthcare delivery on a global scale. Streamlined Operations, Enhanced Care The latest MHOS boasts a suite of powerful features that empower clinics to significantly improve efficiency and patient care. Its key strengths include: Superior Performance: Reduced registration times, streamlined electronic health record ("EHR") system for primary care with functionality to support t
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal 2024 ("H1FY24") ended December 31, 2023, the Company had revenue of approximately $6.6 million, approximately a 120% improvement on revenue of $3.0 million for the same period in fiscal 2023 ("H1FY23"). Telemedicine consultations on the platform increased by approximately 101% during H1FY24, reaching 731,000 compared to 363,000 during H1FY23. The Company believes that this growth was driven by both increased adoption rates and a larger market share. Coupled with the
Gainers Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday's pre-market session. The company's market cap stands at $84.0 million. Neurogene (NASDAQ:NGNE) shares rose 31.92% to $40.0. The company's market cap stands at $519.2 million. Geovax Labs (NASDAQ:GOVX) shares rose 28.94% to $2.45. The company's market cap stands at $6.1 million. SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 24.03% to $3.2. The market value of their outstanding shares is at $29.5 million. Trevena (NASDAQ:TRVN) stock rose 23.33% to $0.44. The market value of their outstanding shares is at $8.0 million. Molecular Partners (NASDAQ:MOLN) stock rose 22.23% to $9.73. The company's
Mobile-health Network Solutions ['MaNaDr'](NASDAQ:MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight management program, improving the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medications?in the Asia-Pacific (APAC) region.
Mobile-health Network Solutions (NASDAQ:MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal 2024 ("H1FY24") ended December 31, 2023, the Company had revenue of approximately $6.6 million, approximately a 120% improvement on revenue of $3.0 million for the same period in fiscal 2023 ("H1FY23").Telemedicine consultations on the platform increased by approximately 101% during H1FY24, reaching 731,000 compared to 363,000 during H1FY23. The Company believes that this growth was driven by both increased adoption rates and a larger market share. Coupled with the implementation of a dynamic pricing model which increas